NovoCure Limited
US ˙ NasdaqGS ˙ JE00BYSS4X48

SecurityNVCR / NovoCure Limited
InstitutionJefferies Group LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Jefferies Group LLC closes position in NVCR / NovoCure Limited

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 0 shares of NovoCure Limited (US:NVCR) valued at $0 USD as of December 31, 2021. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 4,900 shares of NovoCure Limited. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2021-12-31 13F/A-1 NOVOCURE ORD SHS G6674U108 0 -4,900 -100.00 0 -100.00
2022-02-12 2021-12-31 13F NOVOCURE ORD SHS G6674U108 0 -4,900 0
2023-09-21 2021-09-30 13F/A-2 NOVOCURE ORD SHS G6674U108 4,900 4,900 569 0.0041
2021-12-17 2021-09-30 13F/A-1 NOVOCURE ORD SHS G6674U108 4,900 4,900 569 0.0039
2021-11-15 2021-09-30 13F NOVOCURE ORD SHS G6674U108 4,900 4,900 569 0.0037
2023-09-21 2021-03-31 13F/A-1 NOVOCURE ORD SHS G6674U108 0 -13,600 -100.00 0 -100.00
2021-05-14 2021-03-31 13F NOVOCURE ORD SHS G6674U108 0 -13,600 0
2023-09-21 2020-12-31 13F/A-1 NOVOCURE ORD SHS G6674U108 13,600 13,600 2,353 0.0185
2021-02-16 2020-12-31 13F NOVOCURE ORD SHS G6674U108 13,600 13,600 2,353 0.0212
2020-11-13 2020-09-30 13F NOVOCURE ORD SHS G6674U108 0 -35,000 -100.00 0 -100.00
2020-11-02 2020-06-30 13F/A-1 NOVOCURE ORD SHS G6674U108 35,000 35,000 2,076 0.0245
2020-08-14 2020-06-30 13F NOVOCURE ORD SHS G6674U108 35,000 35,000 2,076 27,896.9865
2019-08-14 2019-06-30 13F NOVOCURE ORD SHS G6674U108 0 -6,113 -100.00 0 -100.00
2019-05-15 2019-03-31 13F NOVOCURE ORD SHS G6674U108 6,113 6,113 294 0.0024
2018-02-14 2017-12-31 13F NOVOCURE ORD SHS G6674U108 0 -325,000 -100.00 0 -100.00
2017-11-14 2017-09-30 13F NOVOCURE ORD SHS G6674U108 325,000 325,000 6,451 0.0426
2017-08-14 2017-06-30 13F NOVOCURE ORD SHS G6674U108 0 -10,394 -100.00 0 -100.00
2017-05-15 2017-03-31 13F NOVOCURE ORD SHS G6674U108 10,394 10,394 84 0.0006
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.